|
Volumn 33, Issue 6, 2012, Pages 2117-2123
|
Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CA 125 ANTIGEN;
PROTEIN;
TUMOR MARKER;
WFDC2 PROTEIN, HUMAN;
ADENOCARCINOMA;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CANCER GRADING;
CANCER STAGING;
CASE CONTROL STUDY;
COMPARATIVE STUDY;
CYSTADENOCARCINOMA;
ENDOMETRIUM TUMOR;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FEMALE GENITAL SYSTEM;
FOLLOW UP;
HUMAN;
METABOLISM;
MIDDLE AGED;
OVARY TUMOR;
PATHOLOGY;
PROGNOSIS;
PROSPECTIVE STUDY;
SENSITIVITY AND SPECIFICITY;
TUMOR RECURRENCE;
ADENOCARCINOMA, CLEAR CELL;
ADNEXA UTERI;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
CA-125 ANTIGEN;
CASE-CONTROL STUDIES;
CYSTADENOCARCINOMA, SEROUS;
ENDOMETRIAL NEOPLASMS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MIDDLE AGED;
NEOPLASM GRADING;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
OVARIAN NEOPLASMS;
PROGNOSIS;
PROSPECTIVE STUDIES;
PROTEINS;
SENSITIVITY AND SPECIFICITY;
TUMOR MARKERS, BIOLOGICAL;
YOUNG ADULT;
|
EID: 85027936086
PISSN: None
EISSN: 14230380
Source Type: Journal
DOI: 10.1007/s13277-012-0471-7 Document Type: Article |
Times cited : (64)
|
References (0)
|